Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Embecta Corp. - Common Stock
(NQ:
EMBC
)
6.415
+0.225 (+3.63%)
Delayed Quote
Updated: 2:29 PM EST, Nov 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Embecta Corp. - Common Stock
< Previous
1
2
3
4
Next >
Embecta (EMBC) Q3 2026 Earnings Call Transcript
↗
August 14, 2026
Revenue fell 8.1% year-over-year, but margin guidance rose for fiscal 2026.
Via
The Motley Fool
Topics
Earnings
Embecta Q3 Earnings Call Highlights
↗
August 07, 2026
Embecta (NASDAQ:EMBC) reported fiscal third-quarter 2026 revenue of approximately $272 million, down 8.1% from the prior-year period on a reported basis and down 8.9% on an adjusted constant-currency...
Via
MarketBeat
Topics
Earnings
Embecta (NASDAQ:EMBC) Jumps 9% on Strong Fiscal Q3 Earnings Beat
↗
August 07, 2026
Via
Chartmill
Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification
↗
May 16, 2026
Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and...
Via
MarketBeat
Embecta Corp. (NASDAQ:EMBC) Plunges Over 25% on Q2 Fiscal 2026 Miss
↗
May 05, 2026
Via
Chartmill
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat
↗
February 05, 2026
Via
Chartmill
An Overview of Embecta's Earnings
↗
August 07, 2025
Via
Benzinga
A Peek at Embecta's Future Earnings
↗
May 08, 2025
Via
Benzinga
Why Embecta Stock Plummeted Today
↗
May 05, 2026
Embecta's most recent quarterly report didn't give investors much to be exicited about.
Via
The Motley Fool
Embecta (EMBC) Q2 2026 Earnings Transcript
↗
May 05, 2026
Embecta (EMBC) Q2 2026 Earnings Transcript
Via
The Motley Fool
Keep an eye on the top gainers and losers in Tuesday's session.
↗
May 05, 2026
Via
Chartmill
Which stocks are gapping on Tuesday?
↗
May 05, 2026
Via
Chartmill
Earnings Scheduled For February 6, 2025
↗
February 06, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
May 05, 2026
Via
Chartmill
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
April 03, 2026
As of April 3, 2026, the medical technology landscape is undergoing a radical transformation, and few companies embody this evolution more than Becton, Dickinson and Company (NYSE: BDX). Known...
Via
Finterra
Topics
Artificial Intelligence
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
February 09, 2026
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5...
Via
Finterra
Topics
Artificial Intelligence
Economy
Product Recall
3 Healthcare Stocks Paying the Highest Dividends of 2026
↗
February 06, 2026
Which of the highest-yielding healthcare stocks are value traps or golden opportunities?
Via
The Motley Fool
Embecta (EMBC) Q1 2026 Earnings Call Transcript
↗
February 05, 2026
Embecta (EMBC) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)
January 09, 2026
Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...
Via
PredictStreet
Topics
Economy
Product Recall
World Trade
Embecta (EMBC) Q4 2025 Earnings Call Transcript
↗
November 25, 2025
Embecta (EMBC) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Embecta Corp (NASDAQ:EMBC) Reports Q4 Earnings Miss, Provides FY 2026 Outlook
↗
November 25, 2025
Embecta (EMBC) reported Q4 earnings, missing EPS and revenue estimates. The stock rose as investors focused on the company's positive fiscal 2026 guidance and dividend.
Via
Chartmill
Topics
Earnings
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 08, 2025
Via
Benzinga
Embecta Corp (NASDAQ:EMBC) Surpasses Q3 Earnings Estimates, Shares Jump 10.5% in Pre-Market Trading
↗
August 08, 2025
Embecta Corp (EMBC) beats Q3 2025 earnings estimates with $295.5M revenue and $1.12 EPS, sparking a 10.5% pre-market stock surge. Strong performance may lift full-year forecasts.
Via
Chartmill
Earnings Scheduled For August 8, 2025
↗
August 08, 2025
Via
Benzinga
Why Is Embecta Stock Falling On Friday?
↗
May 09, 2025
Embecta reaffirms earnings outlook, trims revenue forecast, and boosts cash flow as restructuring and cost controls offset tariff and FX headwinds.
Via
Benzinga
Topics
World Trade
Earnings Scheduled For May 9, 2025
↗
May 09, 2025
Via
Benzinga
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business
↗
February 06, 2025
Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.
Via
Benzinga
Activist Starboard Value Pushes Becton Dickinson To Divest Life Sciences Unit
↗
February 03, 2025
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to...
Via
Benzinga
Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
January 14, 2025
Via
Benzinga
Topics
Government
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
